Insurer Seeks Revival Of RICO Suit In Testosterone MDL

Law360 (June 12, 2019, 6:40 PM EDT) -- AbbVie and other makers of testosterone replacement drugs engaged in a fraudulent marketing scheme that led Medical Mutual of Ohio to pay prescription benefits that were medically inappropriate, the insurer told the Seventh Circuit on Tuesday.

In a bid to revive its Racketeer Influenced and Corrupt Organizations Act suit against AbbVie Inc., Eli Lilly and Co., Endo Pharmaceuticals Inc., Actavis Inc. and Auxilium Pharmaceuticals Inc., the insurance company said an Illinois federal court conducted a "backwards" analysis.

Medical Mutual said the court's failure to recognize that the absence of a decision to restrict the availability of benefits for prescriptions of the testosterone...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS